Research Overview · Research Use Only

Semaglutide: research overview

Semaglutide is a synthetic peptide studied as a GLP-1 receptor agonist. It acts on a single incretin pathway, GLP-1, and it is the compound the newer dual and triple agonists are usually measured against. That makes it a common baseline in metabolic peptide research.

What is semaglutide?

Semaglutide belongs to the incretin class of research peptides. It engages the GLP-1 receptor, a pathway involved in glucose-dependent insulin signaling and appetite regulation. Because it targets one well-characterized receptor, semaglutide is frequently used as a reference point when researchers compare newer multi-receptor compounds.

The single-receptor mechanism

• GLP-1 receptor - an incretin pathway central to glucose-dependent insulin signaling and appetite regulation. Semaglutide is a selective agonist of this receptor.

Semaglutide vs. tirzepatide vs. retatrutide

The metabolic peptides differ mainly in how many receptors they engage:

See the companion overviews for tirzepatide and retatrutide, or browse the full research peptide catalog.

Forms & handling in the lab

Semaglutide ships as a lyophilized (freeze-dried) powder, commonly in 10 mg research vials. Before use it is reconstituted with bacteriostatic water, and the water volume you add determines the concentration in mg/mL.

Storage & stability

• Lyophilized powder - most stable form; keep frozen or refrigerated and protected from light until reconstituted.
• Reconstituted solution - refrigerate at roughly 2-8 °C; as a general research guideline, use within about 28 days.
• Avoid repeated freeze-thaw cycles, heat, and shaking, which can degrade the peptide.

Frequently asked questions

Related guides